Pharmaceutical Analysis & Statistics in Oceania Countries, November 2012 (p6)

Blackmores Limited (Symbol:BKL) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
November 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Pharmaceutical
Countries : Australia, South Korea, New Zealand, Singapore

Solagran Limited (SLA) - Financial and Strategic SWOT Analysis Review

$ 250
Company report
November 2012
by Global Data

Summary Solagran Limited (Solagran), formerly known as Solagran International is a biotechnology company. It undertakes research and development, and commercialization of natural and biologically active ...

Industries : Pathology
Countries : Australia, Netherlands, World

Animas Corporation Market Share Analysis

$ 1 000
Company report
October 2012
by Global Data

Animas Corporation Market Share Analysis Summary GlobalData's new report, ?Animas Corporation Market Share Analysis? provides in-depth information on Animas Corporation's market position in the different ...

Industries : Drug Delivery Technology
Countries : World, Canada, United States, Australia, United Kingdom, Europe, North America, Brazil, Spain, Italy, France, Germany, China

Oramed Pharmaceuticals, Inc. - Product Pipeline Review - 2012

$ 1 500
Company report
October 2012
by Global Markets Direct

Oramed Pharmaceuticals, Inc. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Oramed Pharmaceuticals, Inc. - Product Pipeline Review - 2012? provides data on the ...

Industries : Pharmaceutical
Countries : World, United States, New Zealand, South Africa

New Zealand Business Projection Industry Update Quarter 4 2011

$ 1 050
Industry report
October 2012
by Business Monitor International

Core Views We believe the damage caused by the second Christchurch earthquake, ongoing property correction and debt deleveraging will weigh on growth. In view of these factors, we are projecting real ...

Industries : Drug and Medication
Countries : New Zealand

Australia Insulin Delivery Devices Market Trend Forecast to 2018

$ 2 100
Industry report
October 2012
by ABMRG

Short Description This research report provides key market trends, market forecasts and competitive scenario of the insulin delivery devices in Australia through 2018. The product categories covered in ...

Industries : Drug Delivery Technology
Countries : Australia

Australia Hearing Aids Market Trend Forecast to 2018

$ 2 100
Industry report
October 2012
by ABMRG

Short Description This research report provides key market trends, market forecasts and competitive scenario of the hearing aids in Australia through 2018. The product categories covered in this report ...

Industries : Pathology
Countries : Australia

Australia Sleep Apnea Diagnostic Systems Market Trend Forecast to 2018

$ 2 100
Industry report
October 2012
by ABMRG

Short Description This research report provides key market trends, market forecasts and competitive scenario of the sleep apnea diagnostic systems in Australia through 2018. The product categories covered ...

Industries : Pathology
Countries : Australia

Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

$ 3 500
Industry report
September 2012
by Global Data

Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery Summary GlobalData's new report, ?Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose ...

Industries : Pathology
Countries : Australia, China, India, Japan

New Zealand Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

$ 2 500
Industry report
September 2012
by Global Data

New Zealand Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery Summary GlobalData's new report, ?New Zealand Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring ...

Industries : Pathology
Countries : New Zealand

Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

$ 2 500
Industry report
September 2012
by Global Data

Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery Summary GlobalData's new report, ?Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring ...

Industries : Pathology
Countries : Australia

Disease and Therapy Review: Stroke

$ 995
Industry report
September 2012
by Timely Data Resources Inc.

Abstract The Stroke Disease and Therapy Review provides an overview of the condition, with incidence, prevalence, and mortality numbers for major countries worldwide, information on diagnosis, and an overview ...

Industries : Therapy
Countries : World, Europe, Brazil, Canada, Spain, Italy, France, Germany, Japan, India, China, Australia, Russian Federation, South Korea, Mexico, Poland, Greece, Asia, United States, United Kingdom, New Zealand, Sweden, Romania, Ireland, Thailand, Congo, Democratic Republic Of, Oceania, North America, South America

Disease and Therapy Review: ESRD

$ 995
Industry report
September 2012
by Timely Data Resources Inc.

Abstract The End Stage Renal Disease Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers for major countries worldwide, ...

Industries : Therapy
Countries : World, Philippines, Europe, Canada, Spain, Italy, France, Germany, Japan, Australia, Argentina, Netherlands, Bangladesh, Asia, Chile, Brazil, Mexico, Sweden, Russian Federation, Poland, Greece, Thailand, Taiwan, South Korea, India, China, South America, United States, United Kingdom, Colombia, Romania, North America, Oceania

Drug and Medication in Australia: Cephalon, Inc. ? Product Pipeline Review - H2 2011

$ 1 500
Industry report
September 2012
by Global Markets Direct

- Product Pipeline Review - H2 2011? provides a detailed overview on the Cephalon, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest ...

Industries : Drug and Medication
Countries : World, Australia

Drug and Medication in United States: Progen Pharmaceuticals Limited - Product Pipeline Review - Q4 2010

$ 1 500
Industry report
September 2012
by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

Industries : Pharmaceutical
Countries : Australia, World

Pharmaxis Limited - Product Pipeline Review - 2012

$ 1 500
Industry report
September 2012
by Global Markets Direct

Pharmaxis Limited - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Pharmaxis Limited - Product Pipeline Review - 2012? provides data on the Pharmaxis Limited's ...

Industries : Pharmaceutical
Countries : World, United States, Australia

Chemical & Pharmaceutical Plant Construction in Australia to 2016: Market Databook

$ 500
Industry report
September 2012
by Timetric

Synopsis Timetric's 'Chemical & Pharmaceutical Plant Construction in Australia to 2016: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical plants ...

Industries : Pharmaceutical
Countries : Australia

Antibiotics Market in Australia to 2016

$ 652
Industry report
September 2012
by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Australia. The study provides essential market information for decision-makers ...

Industries : Drug and Medication
Countries : Australia

MarketVIEW: Acne vaccines

$ 8 995
Industry report
September 2012
by VacZine Analytics Group Of Assay Advantage Ltd

Acne vulgaris is a common skin condition which is estimated to affect 80% of people at some point between 11 and 30 years of age. The condition ranges from mild to severe with latter more likely to cause ...

Industries : Drug and Medication
Countries : United States, Australia, Canada, Spain, Italy, France, Germany, Japan

Bronchitis - Pipeline Review, H2 2012

$ 2 000
Company report
August 2012
by Global Markets Direct

Bronchitis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Bronchitis - Pipeline Review, H2 2012', provides an overview of the Bronchitis therapeutic pipeline. This report provides information ...

Industries : Pathology
Countries : Australia, World

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012

$ 2 000
Company report
August 2012
by Global Markets Direct

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012', provides an overview ...

Industries : Pathology
Countries : Australia

Disease and Therapy Review: Diabetes

$ 995
Industry report
August 2012
by Timely Data Resources Inc.

Abstract The Diabetes Disease and Therapy Review provides an overview of Type 1 and Type 2 diabetes, with incidence and prevalence numbers for major countries worldwide, information on diagnosis, and an ...

Industries : Therapy
Countries : World, Canada, Spain, Italy, France, Germany, Japan, China, United States, Mexico, Philippines, India, Sudan, Asia, Europe, United Kingdom, Australia, Indonesia, South Africa, Africa, Chile, Vietnam, Thailand, Tanzania, Nigeria, North America

New Zealand Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

$ 1 088
Industry report
August 2012
by Business Monitor International

BMI View: New Zealand's pharmaceutical industry has a classic low risk, low reward profile. Multinational drugmakers are attracted to the country's non-communicable disease burden, direct-toconsumer advertising ...

Industries : Pharmaceutical
Countries : New Zealand

CBio Limited (CBZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
August 2012
by Global Data

CBio Limited (CBZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary CBio Limited ( CBio ) is a research focused biopharmaceutical company targeting on development of technologies fo ...

Industries : Pharmaceutical
Countries : Australia

Australia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

$ 1 088
Industry report
August 2012
by Business Monitor International

BMI View: Australian prospects for multinational drugmakers are mixed. In the first quarter of the year it was announced that eight medicines would not be included in the country's Pharmaceutical Benefits ...

Industries : Pharmaceutical
Countries : Australia

Physiotherapy Services Market in Australia

$ 980
Industry report
July 2012
by Ibisworld

IBISWORLD This is the replacement for IBISWorld's October Physiotherapy Services in Australia About this Market This market research report from IBISWorld provides a in-depth overview of the Physiotherapy ...

Industries : Therapy
Countries : Australia

Sigma Pharmaceuticals Limited (SIP) : Company Profile and SWOT Analysis

$ 120
Company report
July 2012
by World Market Intelligence Ltd

Synopsis World Market Intelligence's 'Sigma Pharmaceuticals Limited (SIP) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains ...

Industries : Pharmacies and Drug Stores
Countries : Australia

Vitamins and Provitamins - Australia

$ 652
Industry report
July 2012
by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for vitamins and provitamins in Australia. The study provides essential market information fo ...

Industries : Vitamin and Supplement
Countries : Australia

MarketVIEW: Candida vaccines

$ 7 995
Industry report
July 2012
by VacZine Analytics Group Of Assay Advantage Ltd

Candida yeasts cause Candidiasis which is a fungal infection commonly found in humans. Infections can occur in the female Genital area "vulvovaginal candidiasis" of which nearly 75% of all adult women ...

Industries : Drug and Medication
Countries : Australia, Canada, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, World, Oceania

MarketVIEW: Herpes Simplex Virus vaccines (therapeutic)

$ 8 995
Industry report
July 2012
by VacZine Analytics Group Of Assay Advantage Ltd

Herpes Simplex Virus (HSV) is a sexually transmitted virus which is a major cause of genital herpes (GH). Although most individuals infected with HSV-2 have minimal signs of infection, the disease is ...

Industries : Drug and Medication
Countries : United States, United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, World